Breaking News Instant updates and real-time market news.

BIIB

Biogen

$341.41

-2.67 (-0.78%)

07:38
08/07/18
08/07
07:38
08/07/18
07:38

Biogen resumed with a Buy at Stifel

Stifel analyst Paul Matteis resumed coverage of Biogen with a Buy rating and a $394 price target, citing his above consensus projections for Spinraza in Spinal Muscular Atrophy and his view that the odds of success for Aducanumab in Alzheimer's are "modestly better than 50/50." While there are real reasons to believe "this time is different" with Aducanumab, Matteis does worry that the floor value in a negative scenario for the Alzheimer's drug might be lower than some think, he tells investors.

BIIB Biogen
$341.41

-2.67 (-0.78%)

07/26/18
07/26/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. PIPER CUTS 3D SYSTEMS TO UNDERWEIGHT: Piper Jaffray analyst Troy Jensen downgraded 3D Systems (DDD) to Underweight from Neutral with a $10 price target. He believes competition for the company's main product lines is intensifying. The analyst also thinks 3D will need to increase spending on direct sales, customer support and consulting, meaning "meaningful profitability" will likely be more challenged than revenue growth throughout 2018. He views the stock as overvalued. While Jensen continues to believe the overall 3D printing industry is "growing rapidly," he remains cautious on shares of 3D Systems and Stratasys (SSYS). He reiterated a Neutral rating on the latter. OPCO CUTS E.L.F. TO PERFORM: Oppenheimer analyst Rupesh Parikh downgraded e.l.f. Beauty (ELF) to Perform from Outperform saying the bull case is more uncertain from here. The analyst does not have a price target for the shares. Recent developments, including "still challenging trends" in the mass category and increased tariff uncertainty, bring greater risk to consensus forecasts, Parikh tells investors in a research note. He is harder-pressed to see the case for share outperformance. Ulta Beauty (ULTA) and Estee Lauder (EL) remain Parikh's top picks in beauty. FACEBOOK GETS MULTIPLE DOWNGRADES AFTER Q2 EARNINGS: Nomura Instinet analyst Mark Kelley downgraded Facebook (FB) to Neutral from Buy after the company delivered "underwhelming" Q2 results and guided for revenue growth deceleration through the end of the year. The revenue guidance paired with the expectation for mid-30% operating margins in the medium term or possibly longer means consensus numbers will be cut "drastically," he said. He lowered his price target on Facebook shares to $183 from $228. Facebook was also downgraded to Neutral from Buy by UBS analyst Eric Sheridan, who also lowered his price target for the shares to $180 from $212, and to Outperform from Strong Buy at Raymond James. Facebook shares are down over 19% in late morning trading. PIPER SAYS BIOGEN SELLOFF A BUYING OPPORTUNITY: Biogen (BIIB) shares "will recover and continue to work" into aducanumab's full Phase 3 data in 2020, Piper Jaffray analyst Christopher Raymond told investors. With the stock having run up into these data, the analyst said he understood the "sell-the-news" phenomenon. He believes, however, that the fundamental concerns he's heard from investors "don't seem to hold water." The analyst said to buy Biogen shares on the selloff. He kept an Overweight rating on the name with a $400 price target.
08/01/18
PIPR
08/01/18
NO CHANGE
Target $400
PIPR
Overweight
Piper recommends Biogen shares after meeting with management
After hosting investor meetings with Biogen investor relations this week, Piper Jaffray analyst Christopher Raymond continues to recommend purchase of the shares. The analyst came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond tells investors in a research note. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on shares of Biogen. He keeps an Overweight rating on the name with a $400 price target.
08/01/18
08/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPGRADES DROPBOX TO BUY: Jefferies analyst John DiFucci upgraded Dropbox (DBX) to Buy from Hold with an unchanged price target of $32. The analyst is not making a call on the Q2 results, which come on August 9. Rather, the upgrade is based "entirely on valuation," he stated. Dropbox is up 4.7% in late morning trading. JEFFERIES UPGRADES PAPA JOHN'S: Jefferies analyst Alexander Slagle upgraded Papa John's (PZZA) to Buy from Hold and raised his price target for the shares to $58 from $52. The stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving, Slagle said. After reviewing the company's potential path to recovery and possible strategic actions that could create shareholder value, the analyst has a bull case of $75 per share. He thinks this outweighs the bear case, or downside risk, of $35 per share. SAREPTA UPGRADED AFTER PULLBACK: Morgan Stanley analyst Matthew Harrison upgraded Sarepta Therapeutics (SRPT) to Overweight from Equal Weight, noting that the stock has given up much of the gains it saw when its initial DMD gene therapy data was announced. He sees the pullback as an opportunity to own the stock near pre-DMD gene therapy levels without taking the binary risk. He doesn't think a major bear case has emerged on the prospects for the company's DMD gene therapy program and he sees major catalysts in the second half of this year that he believes the market is missing. Harrison has a $163 price target on Sarepta shares. PIPER CUTS SHOPIFY TO NEUTRAL: Piper Jaffray analyst Michael Olson downgraded Shopify (SHOP) to Neutral from Overweight and lowered his price target to $145 from $155, saying that Shopify's Q2 was "good, but not good enough" with monthly recurring revenue below investor expectations. While Olson said Shopify is performing well, he believes their performance is mostly reflected in the stock's current valuation. PIPER RECOMMENDS BIOGEN AFTER MANAGEMENT MEETING: After hosting investor meetings with Biogen (BIIB) investor relations this week, Piper Jaffray analyst Christopher Raymond came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond said. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on Biogen. He kept an Overweight rating on shares with a $400 price target.

TODAY'S FREE FLY STORIES

02:50
06/27/19
06/27
02:50
06/27/19
02:50
General news
FX Update: The yen continued to weaken »

FX Update: The yen…

02:00
06/27/19
06/27
02:00
06/27/19
02:00
General news
Asian Market Wrap: »

Asian Market Wrap:…

FSUGY

Fortescue Metals

$0.00

(0.00%)

22:07
06/26/19
06/26
22:07
06/26/19
22:07
Downgrade
Fortescue Metals rating change at Vertical Group »

Fortescue Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCDA

Tricida

$35.08

-0.07 (-0.20%)

22:01
06/26/19
06/26
22:01
06/26/19
22:01
Initiation
Tricida initiated at Goldman Sachs »

Tricida initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

CTL

CenturyLink

$10.91

0.16 (1.49%)

20:54
06/26/19
06/26
20:54
06/26/19
20:54
Upgrade
CenturyLink rating change at Wells Fargo »

CenturyLink upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MORF

Morphic Holdings

$0.00

(0.00%)

20:54
06/26/19
06/26
20:54
06/26/19
20:54
Syndicate
Morphic Holdings 6M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

WBA

Walgreens Boots Alliance

$52.40

-0.59 (-1.11%)

, MKC

McCormick

$150.58

-2.545 (-1.66%)

20:25
06/26/19
06/26
20:25
06/26/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

WBA

Walgreens Boots Alliance

$52.40

-0.59 (-1.11%)

MKC

McCormick

$150.58

-2.545 (-1.66%)

CAG

Conagra Brands

$28.94

0.035 (0.12%)

PDCO

Patterson Companies

$24.90

0.7 (2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

ADPT

Adaptive Biotechnologies

$0.00

(0.00%)

20:17
06/26/19
06/26
20:17
06/26/19
20:17
Syndicate
Adaptive Biotechnologies 15M share IPO priced at $20.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

BBIO

BridgeBio

$0.00

(0.00%)

20:15
06/26/19
06/26
20:15
06/26/19
20:15
Syndicate
BridgeBio 20.5M share IPO priced at $17.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

CHNG

Change Healthcare

$0.00

(0.00%)

20:14
06/26/19
06/26
20:14
06/26/19
20:14
Syndicate
Change Healthcare 42.9M share IPO priced at $13.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 09

    Sep

  • 27

    Jun

INXN

Interxion

$73.09

-1.97 (-2.62%)

20:11
06/26/19
06/26
20:11
06/26/19
20:11
Syndicate
Interxion 4M share Secondary priced at $72.75 »

Citi acted as lead book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

LECO

Lincoln Electric

$80.24

0.1 (0.12%)

20:09
06/26/19
06/26
20:09
06/26/19
20:09
Downgrade
Lincoln Electric rating change at KeyBanc »

Lincoln Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$42.11

-0.64 (-1.50%)

, CMCSK

Comcast

$0.00

(0.00%)

18:55
06/26/19
06/26
18:55
06/26/19
18:55
Periodicals
MSNBC charging markup for ads in first two Dem debates, WSJ says »

Advertisers were asked to…

CMCSA

Comcast

$42.11

-0.64 (-1.50%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MLHR

Herman Miller

$37.86

0.75 (2.02%)

, KBH

KB Home

$23.58

-0.24 (-1.01%)

18:51
06/26/19
06/26
18:51
06/26/19
18:51
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Herman…

MLHR

Herman Miller

$37.86

0.75 (2.02%)

KBH

KB Home

$23.58

-0.24 (-1.01%)

PECK

Peck

$6.50

0.18 (2.85%)

VRCA

Verrica Pharmaceuticals

$9.44

-0.1 (-1.05%)

PIR

Pier 1 Imports

$8.80

0.14 (1.62%)

RAD

Rite Aid

$7.11

0.26 (3.80%)

ACRS

Aclaris Therapeutics

$4.45

0.06 (1.37%)

BA

Boeing

$375.05

5.68 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 17

    Jul

  • 24

    Jul

  • 01

    Oct

  • 02

    Oct

OXY

Occidental Petroleum

$50.42

1.05 (2.13%)

, APC

Anadarko

$70.50

0.41 (0.58%)

18:16
06/26/19
06/26
18:16
06/26/19
18:16
Hot Stocks
Icahn says it is 'important' to add new directors to Occidental's board »

Activist investor Carl…

OXY

Occidental Petroleum

$50.42

1.05 (2.13%)

APC

Anadarko

$70.50

0.41 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

PIR

Pier 1 Imports

$8.80

0.14 (1.62%)

18:15
06/26/19
06/26
18:15
06/26/19
18:15
Hot Stocks
Breaking Hot Stocks news story on Pier 1 Imports »

Pier 1 Imports down 18%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

FB

Facebook

$187.60

-1.27 (-0.67%)

, AMZN

Amazon.com

$1,897.51

18.25 (0.97%)

18:08
06/26/19
06/26
18:08
06/26/19
18:08
Periodicals
Facebook in talks to lease office space in Hudson Yards, WSJ reports »

Facebook (FB) is in…

FB

Facebook

$187.60

-1.27 (-0.67%)

AMZN

Amazon.com

$1,897.51

18.25 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

  • 16

    Jul

NOMD

Nomad Foods

$20.34

-0.24 (-1.17%)

18:05
06/26/19
06/26
18:05
06/26/19
18:05
Initiation
Nomad Foods initiated at Goldman Sachs »

Nomad Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISTR

Investar Holding

$23.35

0.23 (0.99%)

18:04
06/26/19
06/26
18:04
06/26/19
18:04
Hot Stocks
Investar Holding increases quarterly dividend 5% to 5.5c per share »

Investar Holding declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISTR

Investar Holding

$23.35

0.23 (0.99%)

18:02
06/26/19
06/26
18:02
06/26/19
18:02
Hot Stocks
Investar Holding authorizes additional 300,000 share repurchase »

Investar Holding has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$178.77

1.12 (0.63%)

18:00
06/26/19
06/26
18:00
06/26/19
18:00
Hot Stocks
General Dynamics awarded $217M Air Force Intelligence System Support contract »

General Dynamics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$123.23

-0.68 (-0.55%)

, SFTBF

SoftBank

$0.00

(0.00%)

17:50
06/26/19
06/26
17:50
06/26/19
17:50
Periodicals
5 Japanese car makers to invest in Toyota-SoftBank self-driving JV, NAR says »

Five more Japanese car…

TM

Toyota

$123.23

-0.68 (-0.55%)

SFTBF

SoftBank

$0.00

(0.00%)

MZDAF

Mazda

$0.00

(0.00%)

SZKMF

Suzuki

$0.00

(0.00%)

FUJHY

Subaru

$0.00

(0.00%)

ISUZY

Isuzu Motors

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$85.32

0.27 (0.32%)

, BA

Boeing

$375.05

5.68 (1.54%)

17:47
06/26/19
06/26
17:47
06/26/19
17:47
Periodicals
United takes 737 MAX off flying schedule until September 3, Reuters says »

United Airlines (UAL) has…

UAL

United Continental

$85.32

0.27 (0.32%)

BA

Boeing

$375.05

5.68 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 24

    Jul

NOMD

Nomad Foods

$20.34

-0.24 (-1.17%)

17:43
06/26/19
06/26
17:43
06/26/19
17:43
Initiation
Nomad Foods initiated at Goldman Sachs »

Nomad Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$9.45

-0.03 (-0.32%)

, HMNY

Helios and Matheson

$0.00

(0.00%)

17:43
06/26/19
06/26
17:43
06/26/19
17:43
Hot Stocks
AMC Entertainment subscription program A-List surpasses 860K members »

AMC Theatres (AMC) said…

AMC

AMC Entertainment

$9.45

-0.03 (-0.32%)

HMNY

Helios and Matheson

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.